Overview
AFB staining, also known as Ziehl–Neelsen staining, is a special bacteriological staining technique used to demonstrate acid-fast organisms, especially Mycobacterium tuberculosis. The method was originally discovered by Paul Ehrlich and later modified by Ziehl and Neelsen. Acid-fast bacilli possess a waxy, lipid-rich cell wall containing mycolic acids, which enables them to retain the primary stain even after treatment with strong acid-alcohol. Because of this property, AFB staining remains a rapid, simple, and widely used screening test for tuberculosis and other mycobacterial infections.
Symptoms
AFB staining is performed in patients suspected of infections caused by acid-fast organisms. Common clinical features include prolonged cough, fever, weight loss, night sweats, hemoptysis, and fatigue in pulmonary tuberculosis. Extrapulmonary involvement may present with lymph node swelling, pleural effusion, ascites, bone pain, neurological symptoms, or urinary complaints, depending on the site involved. In leprosy, patients may present with skin lesions, sensory loss, and nerve thickening.
Causes
Positive AFB staining is caused by the presence of acid-fast organisms in clinical specimens. The most common cause is Mycobacterium tuberculosis, but other mycobacteria, such as Mycobacterium leprae and nontuberculous mycobacteria, may also be detected. Acid-fastness is due to high mycolic acid content in the bacterial cell wall, which allows retention of carbol fuchsin dye despite acid-alcohol decolorization. Modified ZN staining can also demonstrate partially acid-fast organisms such as Nocardia and certain parasites like Cryptosporidium.
Risk Factors
Risk factors for AFB-positive infections include close contact with infected individuals, overcrowding, poor ventilation, malnutrition, and low socioeconomic status. Immunocompromised states such as HIV infection, diabetes mellitus, chronic kidney disease, malignancy, and prolonged steroid use significantly increase susceptibility. Individuals living in or traveling to tuberculosis-endemic areas and healthcare workers are also at higher risk.
Prevention
Prevention of acid-fast infections focuses on early detection and prompt treatment. Proper collection, transport, and examination of specimens ensure reliable AFB results. Early diagnosis using AFB staining helps reduce disease transmission and guides timely initiation of therapy. Public health measures such as vaccination, infection control practices, contact tracing, and regular screening of high-risk populations play a key role in preventing spread and improving treatment outcomes.
